Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Stem Cell Research & …, 2022 - Springer
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19
disease. Nearly 507 million individuals have been infected with this virus, with …

Translating extracellular vesicle packaging into therapeutic applications

DC Ozkocak, TK Phan, IKH Poon - Frontiers in immunology, 2022 - frontiersin.org
Extracellular vesicles (EVs) are membrane-bound particles released by cells in various
(patho) physiological conditions. EVs can transfer effector molecules and elicit potent …

Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial

M Zarrabi, MA Shahrbaf, M Nouri, F Shekari… - Stem Cell Research & …, 2023 - Springer
Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …

Reactive oxygen species in the adverse outcome pathway framework: Toward creation of harmonized consensus key events

S Tanabe, J O'Brien, KE Tollefsen, Y Kim… - Frontiers in …, 2022 - frontiersin.org
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are formed as a result
of natural cellular processes, intracellular signaling, or as adverse responses associated …

Stromal cell therapy in cats with feline chronic gingivostomatitis: current perspectives and future direction

IL Rivas, M Soltero-Rivera… - Journal of feline …, 2023 - journals.sagepub.com
Feline chronic gingivostomatitis (FCGS) is a painful, immune-mediated, oral mucosal
inflammatory disease in cats. The etiology of FCGS remains unclear, with evidence pointing …

Potency of mesenchymal stem cell and its secretome in treating COVID-19

A Chouw, T Milanda, CR Sartika, MN Kirana… - Regenerative …, 2021 - Springer
The COVID-19 disease, which is caused by the novel coronavirus, SARS-CoV-2, has
affected the world by increasing the mortality rate in 2020. Currently, there is no definite …

Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era

B Singh, G Mal, V Verma, R Tiwari, MI Khan… - Stem Cell Research & …, 2021 - Springer
Background The global health emergency of COVID-19 has necessitated the development
of multiple therapeutic modalities including vaccinations, antivirals, anti-inflammatory, and …

Tendon-derived mesenchymal stem cells (TDSCs) as an in vitro model for virological studies in wild birds

J Rivas, A Dubois, A Blanquer, M Gérardy, U Ziegler… - Viruses, 2023 - mdpi.com
The use of wild animals in research is complicated due to the capture and housing
conditions, as well as to legal aspects, making it difficult to develop in vivo and in vitro …

Stem cell therapy for COVID-19 pneumonia

MM Kebria, PB Milan, N Peyravian, J Kiani… - Molecular …, 2022 - Springer
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus is a highly
contagious microorganism, and despite substantial investigation, no progress has been …

[HTML][HTML] Mesenchymal stem cells: potential role against bacterial infection

B Battah - Journal of Biosciences and Medicines, 2022 - scirp.org
The worldwide spread of bacterial resistance makes finding new therapeutics to overcome
this ongoing problem an urgent need. Mesenchymal stem cells (MSCs) exert potential …